Blue Trust Inc’s Anbio Biotechnology NNNN Stock Holding History

Blue Trust Inc’s Portfolio NNNN Stock Details NNNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5	Closed	-$128	–	2683
2026 Q1	$128	Buy	+5	New	+$130	﹤0.01%	2442

Other funds holding NNNN

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

BFS

Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

Blue Trust Inc's NNNN Position: Q2 2026 in Review

Blue Trust Inc sold out of Anbio Biotechnology (NNNN) in Q2 2026, closing a stake of 5 shares — an estimated $128 sold.

Blue Trust Inc first reported a position in NNNN in Q1 2026 and held it in 1 quarter. The position peaked at $128 in Q1 2026. 2 funds tracked by Wall St. Rank hold NNNN as of Q2 2026.

Blue Trust Inc reported no remaining Anbio Biotechnology position as of Q2 2026 after selling out during the quarter.
Blue Trust Inc sold 5 Anbio Biotechnology shares in Q2 2026, an estimated $128.
Blue Trust Inc first reported a position in Anbio Biotechnology in Q1 2026 and held it in 1 quarter.
Blue Trust Inc's Anbio Biotechnology position peaked at $128 in Q1 2026.
2 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.